Use of Tregs as a cell-based therapy via CD39 for benign prostate hyperplasia with inflammation.
Jin X, Lin T, Yang G, Cai H, Tang B, Liao X, Li H, Chen X, Gong L, Xu H, Sun Y, Tan P, Yin J, Ma H, Ai J, Wang K, Wei Q, Yang L, Li H.
Jin X, et al. Among authors: chen x.
J Cell Mol Med. 2020 May;24(9):5082-5096. doi: 10.1111/jcmm.15137. Epub 2020 Mar 19.
J Cell Mol Med. 2020.
PMID: 32191396
Free PMC article.